Company · CIK 0002044725 · SIC 2834 — Pharmaceutical Preparations · NYSE
Evommune, Inc. · EVMN
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 8, 2026 PForm 4 → | Jul 10, 7:59 pm EDT | Kyle CarverChief Financial Officer | 1,000 | $13.26 | $13,260 | 60,335 | +1.69% | |
| Jul 7, 2026 PForm 4 → | Jul 8, 8:00 pm EDT | Arthur S KirschDirector | 10,000 | $13.30 | $133,000 | 10,000 | — |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.